Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. - Test2 - elhamkhani - TriplyDB

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

http://www.wikidata.org/entity/Q35190216

about

High-dose chemotherapy followed by autologous haematopoietic cell transplantation for children, adolescents and young adults with first recurrence of Ewing sarcoma Management of Ewing sarcoma family of tumors: Current scenario and unmet need Successful allogeneic hematopoietic cell engraftment after a minimal conditioning regimen in children with relapsed or refractory solid tumors Myeloablative therapy against high risk Ewing's sarcoma: A single institution experience and literature review Sarcomas gone bad: what to do about recurrent Ewing sarcoma.High-dose busulfan and melphalan as conditioning regimen for autologous peripheral blood progenitor cell transplantation in high-risk ewing sarcoma patients: a long-term follow-up single-center study.Autologous stem cell transplantation in adults with metastatic sarcoma of the Ewing family: a single centre experience.Myeloablative chemotherapy with autologous stem cell rescue for Ewing sarcoma.Repair of Rat Sciatic Nerve Defects by Using Allogeneic Bone Marrow Mononuclear Cells Combined With Chitosan/Silk Fibroin Scaffold.Consolidation of first-line therapy with busulphan and melphalan, and autologous stem cell rescue in children with Ewing's sarcoma.

P2860

Q24187643-BA4ED412-580D-4CDA-A012-CBF4D849E225 Q28073218-AA81D53B-3578-4B23-9E0F-C9BF71F2C967 Q36398704-3903EC6B-9034-4E67-98A4-042A117B8495 Q37392265-00B20716-F72D-41FD-8BF0-6F14F3CE42C3 Q37890995-11A68125-822A-449C-9D75-0278342CB1E0 Q43082436-501909E3-9A98-4E0B-836B-EC38609925CB Q45903642-BFE42730-0FE2-491D-8880-3C897FB899B7 Q46446521-3FC35497-632F-47D0-80E1-7497E6114AA7 Q50235045-85446053-96A3-4C6F-AC9D-630819E0D47F Q53167841-D9412A53-16DF-467C-98C1-DF1A61F6277C

P2860

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

http://www.wikidata.org/entity/Q35190216

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

@ast

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

@en

type

label

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

@ast

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

@en

prefLabel

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

@ast

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

@en

P1433

Q35190216-4BFEFC31-7496-4C69-B73A-C5C450D9C0D7

P1476

Q35190216-8154A5F7-D1E8-486E-9F75-F41696E05A2C

P2093

Q35190216-0843B968-4281-4B3C-837A-F03D55E871F9

Q35190216-12C62E56-7F29-441C-937A-2C4DA91B6216

Q35190216-5E1A128F-E56E-4110-B489-6B9A57AE7B77

Q35190216-82A9E705-0F68-43DC-883A-E8984DF90CBC

Q35190216-8DEBF91A-A03C-4936-8D5E-28D88A4F0B82

Q35190216-9134F0C0-6479-4CBA-B9B8-3DE58AB9637A

Q35190216-9556EB7A-1CC2-4A55-8B7A-B04157D48983

Q35190216-ACA040A7-3F64-453F-89CC-4602954B405C

Q35190216-AE9B254E-3942-4430-803F-B2D209D804B1

Q35190216-B60C5935-A02D-48E7-9C1E-E2AEF3CA7EA5

P2860

Q35190216-00ACB60F-4498-4E0D-99B9-5F33E763A084

Q35190216-0A4E5905-3881-4593-AB15-92F2DC1BED3F

Q35190216-1347D478-DA18-4404-9075-4B2A6830D495

Q35190216-16EB3BE6-B890-42FF-878F-605269C8D205

Q35190216-1F137120-59BC-4546-8AF3-09BBB20AAFB4

Q35190216-38414F95-9F2A-4FC8-A280-3000E5F55A35

Q35190216-5960DCB2-51FB-4313-8DA8-2729636B43D1

Q35190216-67E3A569-0539-4F8B-99CC-707C6AD956A8

Q35190216-6FAA5906-6D95-4893-A625-3500DDF5D367

Q35190216-9C29049B-7DC9-4AB9-8F30-44C08F62759E

P2888

Q35190216-0818705D-4D5E-4B6B-8A8C-731E892AD99A

P304

Q35190216-9B7CC23A-6A3A-4752-8E20-A567BBC5D543

P31

Q35190216-072FC0A4-995F-4517-A87F-B2DF4CF62D4D

P356

Q35190216-4F678750-24B9-4933-8238-59E850095C6F

P407

Q35190216-C16A22FB-C990-430F-ADF7-991EE2AF3570

P433

Q35190216-85812972-9A2D-4A93-9730-233A2D32F399

P478

Q35190216-26F849C4-A97A-44D0-B28D-82B4C189DDD0

P577

Q35190216-FF624896-30E0-41CB-878F-838EF255EC4B

P5875

Q35190216-4C6FCD83-D81F-4716-93AA-D879D1F834D6

P698

Q35190216-6615977B-3343-4CED-8F28-13FDB9CF3280

P932

Q35190216-4D145A8B-CBEC-4EB2-BE28-D2A01A3C0988

P356

P1433

Bone Marrow Transplantation

P1476

Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma.

@en

P2093

A C Grovas

http://www.w3.org/2001/XMLSchema#string

A R Chen

http://www.w3.org/2001/XMLSchema#string

B M Camitta

http://www.w3.org/2001/XMLSchema#string

C Boudreau

http://www.w3.org/2001/XMLSchema#string

G A Hale

http://www.w3.org/2001/XMLSchema#string

H M Lazarus

http://www.w3.org/2001/XMLSchema#string

J Carreras

http://www.w3.org/2001/XMLSchema#string

J R Edwards

http://www.w3.org/2001/XMLSchema#string

M Arora

http://www.w3.org/2001/XMLSchema#string

M Eapen

http://www.w3.org/2001/XMLSchema#string

P2860

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.

Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling.

Impact of megatherapy in children with high-risk Ewing's tumours in complete remission: a report from the EBMT Solid Tumour Registry.

High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma.

High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis.

The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.

Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.

Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.

Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcoma.

P2888

P304

867-872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/BMT.2008.2

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5606292

http://www.w3.org/2001/XMLSchema#string

P698

18246113

http://www.w3.org/2001/XMLSchema#string

P932

3164955

http://www.w3.org/2001/XMLSchema#string